Enriqueta Felip
MD, PhD
Head of Thoracic Oncology Unit
👥Biography 个人简介
Dr. Enriqueta Felip is one of Europe's foremost thoracic oncologists and a principal investigator in landmark trials including those evaluating amivantamab, the EGFR-MET bispecific antibody, in combination with osimertinib. Her work spans MET amplification as a resistance mechanism in EGFR-mutant NSCLC and the rational design of combination strategies to overcome this. She is a key opinion leader in European lung cancer treatment guidelines.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Enriqueta Felip 的研究动态
Follow Enriqueta Felip's research updates
留下邮箱，当我们发布与 Enriqueta Felip（Vall d'Hebron Institute of Oncology）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment